Search results
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
Morningstar· 6 days agoNEW YORK, June 15, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA). Such investors ...
Pfizer Inc. (NYSE:PFE) Position Increased by V Square Quantitative Management LLC
ETF DAILY NEWS· 6 days agoThe institutional investor owned 20,985 shares of the biopharmaceutical company’s stock after acquiring an additional 15,158 shares during the period. V Square Quantitative ...
Vanguard Group Inc. Sells 210,463 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 4 days agoVanguard Group Inc. lessened its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 0.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange ...
Worried you missed the Nvidia bandwagon? Here are some alternative stocks.
MarketWatch via Yahoo Finance· 6 days agoIt is interesting to see Tesla on the list. The stock has fallen 27% this year, but it is down only...
Moderna stock is lone omen of bird flu pandemic
Reuters· 4 days agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 3 days agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
Personalis Inc. executive sells over $6,500 in company stock By Investing.com
Investing.com· 1 day agoPersonalis, Inc. (NASDAQ:PSNL) has reported a recent transaction by Chief Medical Officer and EVP,...
Personalis executive sells over $2,000 in stock at $1.27-$1.29 range By Investing.com
Investing.com· 1 day agoStephen Michael Moore, the Senior Vice President and Chief Legal Officer at Personalis, Inc....
Gateway - Quartz
Quartz· 3 days agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1 bird flu vaccine, as the virus continues to spread rapidly among poultry ...
Arcturus Therapeutics (NASDAQ:ARCT) Shares Gap Down to $31.00
ETF DAILY NEWS· 4 days agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report)’s share price gapped down prior to trading on Monday . The stock had previously closed at $31.00, but opened ...